期刊文献+

心力衰竭合并心律失常患者行胺碘酮治疗疗效研究 被引量:5

Research on Treatment Efficacy of Patients with Heart Failure Combining Arrhythmia Subjecting to Amiodarone
下载PDF
导出
摘要 目的:研究胺碘酮对心力衰竭合并心律失常患者的临床疗效。方法:选取2011年5月-2013年5月笔者所在医院收治的80例心力衰竭合并心律失常患者,按照治疗方法的不同将其分为两组,对照组和观察组,各40例。对照组进行常规治疗,观察组在常规治疗的基础上静脉注射胺碘酮溶液,观察并记录两组患者的疗效以及不良反应。结果:观察组治疗总有效率为95.0%,高于对照组的65.0%,差异有统计学意义(P<0.05)。观察组心电图改善情况优于对照组(P<0.05),不良反应发生情况少于对照组(P<0.05)。结论:胺碘酮治疗心力衰竭合并心律失常能够改善患者的心功能,有提升治疗效果作用,未出现严重的不良反应,疗效明显且安全性高,值得在临床上推广使用。 Objective:To study clinical efficacy of amiodarone on patients with heart failure combining arrhythmia.Method:Selection from May 2011 to May 2013,the author’s hospital treated 80 cases of patients with heart failure combined arrhythmia,according to the different method of treatment to be divided into two groups,control group and observation group,40 cases in each. Control group routine treatment,the observation group on the basis of routine therapy intravenous amiodarone solution,observe and record the curative effect and adverse reaction of two groups of patients.Result:Observation group treatment the total effective rate was 95.0%higher than that of control group 65.0%,the difference was statistically significant (P〈0.05). Group of electrocardiogram (ecg) was observed is better than that of control group(P〈0.05),adverse reaction happening less than the control group(P〈0.05).Conclusion:The treatment of amiodarone on heart failure combining arrhythmia is capable of improving cardiac function of patients and delivers the effect of improving therapeutic effect,no serious adverse reaction is found,the efficacy is of significance and high safety,being worthy of promotion and application in clinical practices.
作者 杨崇哲 张颖
出处 《中外医学研究》 2014年第11期3-4,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 广东省自然科学基金(项目编号:S2011040001711)
关键词 心力衰竭 心律失常 胺碘酮 Heart Failure Arrhythmias Amiodarone
  • 相关文献

参考文献6

二级参考文献29

  • 1武保华,王向明,刘志明.老年室性心律失常患者应用胺碘酮最佳剂量探讨[J].中国煤炭工业医学杂志,2007,10(1):35-35. 被引量:4
  • 2侯玉萍.胺碘酮治疗充血性心力衰竭并发室性心律失常疗效观察[J].中国误诊学杂志,2007,7(3):454-455. 被引量:5
  • 3王桐玲.胺碘酮治疗急性心肌梗死并发室性心律失常28例[J].河北医药,2007,29(6):541-541. 被引量:9
  • 4胡大一,郭继鸿.中华心律学[M].北京:人民卫生出版社,2008:188-193.
  • 5Hassapoyannes CA,McLaurin BT, Homung CA,et al. Normokinesia adjacent to left ventricular aneurysm:a differential risk for sudden cardiac death[J]. Eur J Heart Fail,2002,4(1 ) : 33-40.
  • 6Epstein AE,Hallstrom AP,Rogers WJ,et al. Mortality following ventricular arrhythmia suppression by encainide, -qccainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST)[J].JAMA, 1993,270 (20) : 2451-2455.
  • 7Bente B. Hanne E, Li J, et al. QT dispersion has no prognostic information of patients with advanced congestive heart failure and reduced left ventricular systolic. Circulation, 2001, 103: 831 -835.
  • 8Dysrhythmias in heart failure. J Cardiovasc Nurs,2004,19(6 Sup- pl) :Sll -26.
  • 9Doval HC, Nul DR, Grancelli He, et al. Randomized trial of low -dose amiodarone in severe congestive heart failure. Lancet, 1994,344:493 - 498.
  • 10Miller JM, Zipes DP. Therapy for cardiac arrhythmias. In:Zipos DP, tabby PBR, Braunwald E. eds : Braunwald's heart disease : a textbook of cardiovascular medicine. Philadelphia: WB Sanndens, 2005:730 - 731.

共引文献52

同被引文献40

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部